Brand Name: Imatero
Generic Name: Imatinib mesylate
Manufacturer: Hetero
Dosage Form: Tablet
Strength: 100mg and 400mg
Composition: Imatinib mesylate
Indication: Blood cancer
Packaging: 10 tablets (10 / strip)
Storage: Store at room temperature
Overview
Imatero (Imatinib mesylate) tablet is used in the treatment of blood cancer (chronic myeloid leukemia and Acute lymphocytic leukemia) and gastrointestinal stromal tumor. It belongs to a family of medications known as tyrosine kinase inhibitors. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in BCR-ABL positive cells (cancer cells). It is important to take this medicine as prescribed by your doctor. The recommended dose of Imatib tablet is decided by a doctor according to your previous medical condition and response to the treatment. Do not stop the use of Imatib tablets without consulting with your doctor. If you experience any signs and symptoms while receiving this medicine, inform your doctor immediately.
Pharmacodynamics
Imatinib Mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in CML. It inhibits proliferation and induces apoptosis in BCR-ABL positive cell lines as well as fresh leukemic cells from Philadelphia chromosome-positive chronic myeloid leukemia.
Interactions
Imatero tablets can interact with other medications and it may increase the risk for side effects.
Don’t forget to disclose and discuss your previous medical history with the doctor.
Medicine Interactions
● Colchicine
● Warfarin
● Pimozide
● Etanercept
● Apalutamide
● Mitotane
● Baricitinib
Disease Interactions
● Fluid retention
● Kidney impairment
● Cardiovascular disease
● Liver impairment
● Bone marrow suppression
Alcohol Interaction
● Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Contraindications
● Do not take this medicine if you are allergic to Imatinib mesylate.
● Imatero (Imatinib mesylate) medicine is not recommended in patients known to be hypersensitive.


